Xeris Biopharma: Q1 Earnings Snapshot

Published: 2026-05-07 07:19:09 ET XERS

Published on 05/07/2026 at 07:19 am EDT

CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported first-quarter net income of $2.2 million.

On a per-share basis, the Chicago-based company said it had profit of 1 cent.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was breakeven on a per-share basis.

The company posted revenue of $83.1 million in the period, also beating Street forecasts. Four analysts surveyed by Zacks expected $80 million.

Xeris Biopharma expects full-year revenue in the range of $380 million to $390 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News